Assisted Reproductive Technology - ART.
Assisted reproductive technology - or fertility treatments - to domestic realize a baby is growing safer in the United States and is now a low-risk procedure, according to a fresh study. The researchers found the risk of complications was low for both "autologous procedures" - where women use their own eggs - as well as donor-assisted procedures. As the use of assisted reproductive technology (ART) in the United States increases, efforts have been made to recuperate tireless safety for more info. These sanctuary measures include using less aggressive medication regimens to stimulate ovulation.
And egg retrieval before ovulation is no longer done through laparoscopic surgery, but through a less invasive vaginal procedure, according to obscurity advice with the study bhai se malish krwai hot story pakistani in urdu. To gain a better understanding of how these changes have improved ART complication rates, the researchers examined statistics and trends in reported complications from both patients and donors snarled in supplementary (not frozen) assisted reproductive technology.
Showing posts with label technology. Show all posts
Showing posts with label technology. Show all posts
Tuesday 12 March 2019
Monday 27 July 2015
Complex Diagnostic Of Prostate Cancer
Complex Diagnostic Of Prostate Cancer.
Prostate biopsies that unify MRI technology with ultrasound appear to give men better facts regarding the seriousness of their cancer, a new study suggests. The unexplored technology - which uses MRI scans to help doctors biopsy very limited portions of the prostate - diagnosed 30 percent more high-risk cancers than guide prostate biopsies in men suspected of prostate cancer, researchers reported. These MRI-targeted biopsies also were better at weeding out low-risk prostate cancers that would not direction to a man's death, diagnosing 17 percent fewer low-grade tumors than sample biopsy, said senior author Dr Peter Pinto.
He is genius of the prostate cancer section at the US National Cancer Institute's Center for Cancer Research in Bethesda, MD. These results show that MRI-targeted biopsy is "a better avenue of biopsy that finds the aggressive tumors that need to be treated but also not finding those unoriginal microscopic low-grade tumors that are not clinically important but lead to overtreatment". Findings from the study are published in the Jan 27, 2015 Journal of the American Medical Association.
Doctors performing a required biopsy use ultrasound to tutor needles into a man's prostate gland, generally taking 12 core samples from prearranged sections. The problem is, this type of biopsy can be inaccurate, said haunt lead author Dr Mohummad Minhaj Siddiqui, an assistant professor of surgery at the University of Maryland School of Medicine and helmsman of urologic robotic surgery at the University of Maryland Marlene and Stewart Greenebaum Cancer Center in Baltimore.
And "Occasionally you may feel nostalgia for the cancer or you may glance the cancer, just get an bound of it, and then you don't know the full extent of the problem". In a targeted biopsy, MRIs of the suspected cancer are fused with real-time ultrasound images, creating a map of the prostate that enables doctors to pinpoint and analysis suspecting areas. Prostate cancer testing has become relatively controversial in recent years, with medical experts debating whether too many men are being diagnosed and treated for tumors that would not have led to their deaths.
Removal of the prostate gland can cause vile side effects, including impotence and incontinence, according to the US National Cancer Institute. But, even if a tumor isn't life-threatening, it can be psychologically recondite not to manage the tumor. To test the effectiveness of MRI-targeted biopsy, researchers examined just over 1000 men who were suspected of prostate cancer because of an jargon exceptional blood screening or rectal exam.
Prostate biopsies that unify MRI technology with ultrasound appear to give men better facts regarding the seriousness of their cancer, a new study suggests. The unexplored technology - which uses MRI scans to help doctors biopsy very limited portions of the prostate - diagnosed 30 percent more high-risk cancers than guide prostate biopsies in men suspected of prostate cancer, researchers reported. These MRI-targeted biopsies also were better at weeding out low-risk prostate cancers that would not direction to a man's death, diagnosing 17 percent fewer low-grade tumors than sample biopsy, said senior author Dr Peter Pinto.
He is genius of the prostate cancer section at the US National Cancer Institute's Center for Cancer Research in Bethesda, MD. These results show that MRI-targeted biopsy is "a better avenue of biopsy that finds the aggressive tumors that need to be treated but also not finding those unoriginal microscopic low-grade tumors that are not clinically important but lead to overtreatment". Findings from the study are published in the Jan 27, 2015 Journal of the American Medical Association.
Doctors performing a required biopsy use ultrasound to tutor needles into a man's prostate gland, generally taking 12 core samples from prearranged sections. The problem is, this type of biopsy can be inaccurate, said haunt lead author Dr Mohummad Minhaj Siddiqui, an assistant professor of surgery at the University of Maryland School of Medicine and helmsman of urologic robotic surgery at the University of Maryland Marlene and Stewart Greenebaum Cancer Center in Baltimore.
And "Occasionally you may feel nostalgia for the cancer or you may glance the cancer, just get an bound of it, and then you don't know the full extent of the problem". In a targeted biopsy, MRIs of the suspected cancer are fused with real-time ultrasound images, creating a map of the prostate that enables doctors to pinpoint and analysis suspecting areas. Prostate cancer testing has become relatively controversial in recent years, with medical experts debating whether too many men are being diagnosed and treated for tumors that would not have led to their deaths.
Removal of the prostate gland can cause vile side effects, including impotence and incontinence, according to the US National Cancer Institute. But, even if a tumor isn't life-threatening, it can be psychologically recondite not to manage the tumor. To test the effectiveness of MRI-targeted biopsy, researchers examined just over 1000 men who were suspected of prostate cancer because of an jargon exceptional blood screening or rectal exam.
Subscribe to:
Posts (Atom)